Oncology & Hematology Coding Alert
Confirm Severity When Coding Dysplasia of the Prostate
Question: Our physician documented dysplasia of prostate for an elderly patient. How can we report this diagnosis? Is dysplasia considered as primary neoplasm of prostate?
Arizona Subscriber
Answer: When your physician documents dysplasia, ICD-10-CM directs you to neoplasia, intraepithelial, prostate. The appropriate ICD-10-CM codes depend on the documented severity.
What is dysplasia? Dysplasia is an erroneous development in cells at an early stage in cancer. There may be a proliferation of cells of abnormal morphology and function.
Carcinoma in situ implies that the abnormal cells remain confined to where they originated and do not spread to deeper or adjacent tissues. When the cancer cells are confined within the epithelium where they originated, it is called primary intraepithelial neoplasm (PIN). Depending upon the depth and extent of spread of the abnormal cells, PIN can be of grade I, II, and III.
PIN Codes: If your provider documents PIN III, you should use D07.5. If your provider documents PIN I, PIN II or does not specify severity, you should use N42.3 (Dysplasia of prostate).
Primary malignancy: For primary malignancy in the prostate, you submit code C61 (Malignant neoplasm of prostate).
Oncology & Hematology Coding Alert
- 2016 Update:
Understand These Basics Before You Can Bill for Advance Care Planning
Submit codes 99497 and +99498 on the same date as chronic care management, and in [...] - Beneficiaries Seek Benefits In Advance Care Planning Services
Last year, the Kaiser Family Foundation conducted a survey prior to the release of final [...] - Screening Refresher:
G0472: Do Not Miss Payment For Hepatitis C Screening
Reserve repeat annual screening only for the high risk patients. When your physician screens a [...] - HCPCS Update:
Update How You Report Keytruda® and Cryamza, Thanks to 2016 Changes
Prepare to include J9271 and J9308 in the list of your chemo codes. Here are [...] - Indications, Formulations, Dosage and Administration of Pembrolizumab and Ramucirumab
Pembrolizumab Indications: Pembrolizumab is used in metastatic NSCLC that expresses PD-L1 and whose disease progressed [...] - You Be the Coder:
Confirm Severity When Coding Dysplasia of the Prostate
Question: Our physician documented dysplasia of prostate for an elderly patient. How can we report this [...] - Reader Question:
Submit Only One Code for Infusion, Injection, and Hydration
Question: It is possible to bill for non-chemo infusion 96365 and 96367 and hydration therapy 96360 [...] - Reader Question:
Submit 1 unit of J3430 for Every mg of Vitamin K
Question: In a patient with bleeding disorder, our physician administered an injection of vitamin K. How [...] - Reader Question:
Procedure Codes Include Preparation
Question: In a patient planned for a biopsy, our physician did an evaluation for about 20 [...]
